Should bisphosphonates be the treatment of choice for metastatic bone disease?

被引：27

作者：

Coleman, RE ^{[1
]}

机构：

[1] Weston Pk Hosp, Canc Res Ctr, Dept Clin Oncol, Sheffield, S Yorkshire, England

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1053/sonc.2001.25427

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：35 / 41

页数：7

相关论文

共 35 条

[1] [Anonymous], BISPHOSPHONATES BONE
[2] EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA
BELCH, AR
BERGSAGEL, DE
WILSON, K
OREILLY, S
WILSON, J
SUTTON, D
PATER, J
JOHNSTON, D
ZEE, B
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) : 1397 - 1402
[3] Berenson J., 2000, Breast Cancer Research and Treatment, V64, P32
[4] BERENSON J, 2000, BREAST CANC RES TREA, V64, P1
[5] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
Berenson, JR
Lichtenstein, A
Porter, L
Dimopoulos, MA
Bordoni, R
George, S
Lipton, A
Keller, A
Ballester, O
Kovacs, MJ
Blacklock, HA
Bell, R
Simeone, J
Reitsma, DJ
Heffernan, M
Seaman, J
Knight, RD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
[6] Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events
Berenson, JR
Lichtenstein, A
Porter, L
Dimopoulos, MA
Bordoni, R
George, S
Lipton, A
Keller, A
Ballester, O
Kovacs, M
Blacklock, H
Bell, R
Simeone, JF
Reitsma, DJ
Heffernan, M
Seaman, J
Knight, RD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 593 - 602
[7] BERENSON JR, IN PRESS CANCER
[8] Blamey R, 1999, EUR J SURG ONCOL, V25, P3
[9] A dose-finding study of zoledronate in hypercalcemic cancer patients
Body, JJ
Lortholary, A
Romieu, G
Vigneron, AM
Ford, J
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) : 1557 - 1561
[10] BODY JJ, 1999, P AN M AM SOC CLIN, V18, pA575

← 1 2 3 4 →